- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quest Diagnostics Incorporated (DGX)
Quest Diagnostics Incorporated stock price live, this page displays NYSE DGX stock exchange data. View the DGX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Quest Diagnostics Incorporated real time stock price chart below.
What Is the Quest Diagnostics Incorporated Stock Price Today?
The Quest Diagnostics Incorporated stock price today is 179.43.
What Is the Stock Symbol for Quest Diagnostics Incorporated?
The stock symbol for Quest Diagnostics Incorporated is "DGX."
What Stock Exchange Does Quest Diagnostics Incorporated Trade On?
Quest Diagnostics Incorporated is listed and trades on the NYSE stock exchange.
Is Quest Diagnostics Incorporated a Good Stock to Buy?
Determining whether Quest Diagnostics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DGX quote. (ISIN: US74834L1008)
What Is the Quest Diagnostics Incorporated Stock Price Today?
The Quest Diagnostics Incorporated stock price today is 179.43.
What Is the Stock Symbol for Quest Diagnostics Incorporated?
The stock symbol for Quest Diagnostics Incorporated is "DGX."
What Stock Exchange Does Quest Diagnostics Incorporated Trade On?
Quest Diagnostics Incorporated is listed and trades on the NYSE stock exchange.
Is Quest Diagnostics Incorporated a Good Stock to Buy?
Determining whether Quest Diagnostics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DGX quote. (ISIN: US74834L1008)
179.43
-0.35(-0.19%)
Closed·
After Hours
179.430.00(0.00%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
178.75
181.00
52 wk Range
135.47
182.38
DGX Scorecard
Full Analysis
Has raised its dividend for 13 consecutive years
DGX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
178.75181.00
52 wk Range
135.47182.38
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DGX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
183.92
Upside
+2.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
9 analysts have revised their earnings upwards for the upcoming period
Quest Diagnostics Incorporated Company Profile
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated Earnings Call Summary for Q1/2025
- Quest Diagnostics Q1 2025 EPS of $2.21 beat estimates; revenue up 12.1% YoY to $2.65B
- Stock surged 6.61% post-earnings; company maintains $19.2B market cap and 'GOOD' financial health
- Launched innovative tests including AD DETECT for Alzheimer's; organic revenue grew 2.4%
- Reaffirmed FY2025 guidance: revenue $10.7-10.85B, adjusted EPS $9.55-9.80
- Expects 3% organic growth; manages challenges of wage inflation and economic uncertainties
Last Updated: 2025-04-22, 09:50 a/m
Read Full TranscriptCompare DGX to Peers and Sector
Metrics to compare | DGX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDGXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.5x | −5.5x | −0.5x | |
PEG Ratio | 3.50 | −0.13 | 0.00 | |
Price/Book | 2.9x | 1.5x | 2.6x | |
Price / LTM Sales | 2.0x | 1.4x | 3.0x | |
Upside (Analyst Target) | 5.3% | 94.4% | 52.6% | |
Fair Value Upside | Unlock | 19.0% | 8.8% | Unlock |
Analyst Ratings
9 Buy
9 Hold
1 Sell
Ratings:
19 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 183.92
(+2.50% Upside)
Earnings
Latest Release
Apr 22, 2025
EPS / Forecast
2.21 / 2.16
Revenue / Forecast
2.65B / 2.64B
People Also Watch
FAQ
What Is the Quest Diagnostics (DGX) Stock Price Today?
The Quest Diagnostics stock price today is 179.43
What Stock Exchange Does Quest Diagnostics Trade On?
Quest Diagnostics is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Quest Diagnostics?
The stock symbol for Quest Diagnostics is "DGX."
Does Quest Diagnostics Pay Dividends? What’s The Current Dividend Yield?
The Quest Diagnostics dividend yield is 1.78%.
What Is the Quest Diagnostics Market Cap?
As of today, Quest Diagnostics market cap is 20.03B.
What Is Quest Diagnostics's Earnings Per Share (TTM)?
The Quest Diagnostics EPS (TTM) is 8.04.
When Is the Next Quest Diagnostics Earnings Date?
Quest Diagnostics will release its next earnings report on Jul 23, 2025.
From a Technical Analysis Perspective, Is DGX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Quest Diagnostics Stock Split?
Quest Diagnostics has split 2 times.
How Many Employees Does Quest Diagnostics Have?
Quest Diagnostics has 50500 employees.
What is the current trading status of Quest Diagnostics (DGX)?
As of Jun 22, 2025, Quest Diagnostics (DGX) is trading at a price of 179.43, with a previous close of 179.78. The stock has fluctuated within a day range of 178.75 to 181.00, while its 52-week range spans from 135.47 to 182.38.
What Is Quest Diagnostics (DGX) Price Target According to Analysts?
The average 12-month price target for Quest Diagnostics is USD183.92294, with a high estimate of USD200 and a low estimate of USD158.69. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +2.50% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.